-----:0
Expresses the sense of the Senate that: (1) the Centers for Disease Control and Prevention (CDC) should identify and collect data on racial disparities in the incidence and prevalence of hypertension, and (2) the Department of Health and Human Services should coordinate the collection and analysis of such data with the Department of Defense (DOD), Centers for Disease Control and Prevention (CDC), and the National Heart, Lung, and Blood Institute.
-----:1
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide for the conduct and dissemination of an updated review of studies on the methodology and impact of tomato products on prostate cancer incidence and the risk of such cancer.
-----:2
Chronic hcv infection and liver fibrosis: A descriptive study - Amends the Federal Food, Drug, and Cosmetic Act to provide new criteria for treating chronic hcv infection. Defines: (1) "chronic hcv infection" as infection that is mild in serum transaminase levels and does not cause significant clinical symptoms; and (2) "chronic hcv infection" as infection that is elevated in serum transaminase levels and does not cause significant clinical symptoms. Provides guidelines for treating chronic hcv infection.
-----:3
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration (HRSA), to report to Congress regarding the policies and practices of foreign countries regarding replacement blood donors.
Directs the Secretary to establish a pilot program in the United States for the development and implementation of policies and practices for voluntary blood donor procurement. Requires the Secretary to report to Congress regarding such programs and the extent to which foreign countries are implementing such policies and practices.
-----:4
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to submit to the appropriate congressional committees a report containing: (1) a list of proteins known to have an interaction with a species; (2) a list of proteins known to have an interaction with any other species within a protein interaction network; and (3) a list of proteins within such network that have an interaction with any other species. Directs the Secretary to ensure that: (1) such report is made available to the public on the Internet and posted on the Internet sites of the Department of Health and Human Services; and (2) a comparable report is made available to the public on other Internet sites of the Departments of Education, Labor, Justice, and State, as well as on the Internet sites of the Department of Defense, the National Aeronautics and Space Administration, and the National Institute of Standards and Technology. 
Directs the Secretary to submit to the appropriate congressional committees a report containing: (1) a list of proteins known to have an interaction with a species; (2) a list of proteins within a protein interaction network that have an interaction with any other species; and (3) a list of proteins within such network that have an interaction with any other species.
-----:5
Disulfiram should be used at the lowest effective dose, possibly 250 mg per day, only while prescribing it before starting treatment for patients with personal and familial psychotic symptoms and family history that should be performed before starting treatment with disulfiram (the recommended initial dosage is 500 per day, followed by a maintenance dosage of 250 mg per day).
-----:6
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to offer to enter into a cooperative agreement with the governments of Mexico, Canada, and the United States to: (1) identify, test, and develop new strategies to prevent the spread of malfestina, an invasive species of insects, in Mexico; and (2) provide technical assistance to such governments in using prevention and control strategies with respect to such insects. Requires the Secretary to enter into such agreements with the governments of Mexico, Canada, and the United States to: (1) identify, test, and develop new strategies to prevent the spread of malfestina; and (2) provide technical assistance to such governments in using prevention and control strategies with respect to such insects. (Sec. 3) Directs the Secretary to: (1) enter into such an agreement with the governments of Mexico, Canada, and the United States to identify, test, and develop new strategies to prevent the spread of malfestina; and (2) provide technical assistance to such governments in using prevention and control strategies with respect to such insects.
-----:7
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to ensure that the data from this study are made available to the public and posted on the CDC website.
-----:8
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the National Institute of Diabetes and Digestive and Kidney Diseases to: (1) conduct research to evaluate the relationship between low levels of srage and development of diabetes; and (2) support the development of new technologies to improve the diagnosis, prevention, and treatment of diabetes.
Directs the Secretary, acting through the Director of the CDC, to: (1) conduct research to evaluate the relationship between low levels of srage and development of diabetes; and (2) support the development of new technologies to improve the diagnosis, prevention, and treatment of diabetes.
-----:9
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make grants to eligible public or nonprofit private entities to carry out this study. Authorizes appropriations.
-----:10
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Cancer Institute to conduct a study on the status of small cell carcinoma of the bladder, and to report on the results of such study.
-----:11
Entitles the Secretary of Health and Human Services to provide any assistance necessary to carry out this Act, and to take steps necessary to ensure that sufficient funds are made available to carry it out. Requires the Secretary to report to the appropriate congressional committees on the efforts made by the Department of Health and Human Services to carry out this Act, and on any other issues that may befall the Department as a result of this Act, including the extent to which it has provided for the delivery of essential services to the people of the United States during the period beginning on September 11, 2001, and ending on December 31, 2003.
Directs the Secretary to report to the appropriate congressional committees on the efforts made by the Department of Health and Human Services to carry out this Act, and on any other issues that may befall the Department as a result of this Act, including the extent to which it has provided for the delivery of essential services to the people of the United States during the period beginning on September 11, 2001, and ending on December 31, 2003.
-----:12
Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the CDC to: (1) monitor the collection and testing of brain and other tissues from patients with medblastoma, (2) monitor and test for the presence or absence of human polyoma virus in medblastoma tissues, and (3) make available to the public information regarding the presence or absence of human polyoma virus in medblastoma tissues.

Requires the Secretary to: (1) determine the prevalence and incidence of medblastoma, and (2) expand the collection and testing of brain and other tissues from patients with medblastoma to determine the prevalence and incidence of human polyoma virus in such tissues.

Directs the Secretary to: (1) expand the collection and testing of brain and other tissues from patients with medblastoma to determine the prevalence and incidence of human polyoma virus in such tissues, and (2) make available to the public information regarding the presence or absence of human polyoma virus in such tissues.
-----:13
Expresses the sense of the Senate that: (1) the Food and Drug Administration (FDA) should issue guidance on the use of bexal antimicrobials, and (2) the Centers for Disease Control and Prevention (CDC) should collect data on the prevalence of infections caused by bexal antimicrobials and update such guidance as necessary. Amends the Federal Food, Drug, and Cosmetic Act to require the FDA to issue guidance on the use of bexal antimicrobials in hospital settings. Requires the CDC to collect data on the prevalence of infections caused by bexal antimicrobials in hospital settings and report such data to the Secretary of Health and Human Services (HHS) and the Director of the Centers for Disease Control and Prevention (CDC).
-----:14
femorotabular impingement research - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate research programs related to femorotabular impingement, including research conducted by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). Authorizes appropriations.
-----:15
Food Security and Nutrition Act of 2012 - Amends the Food, Conservation, and Energy Act of 2008 to authorize the Secretary of Agriculture, acting through the Director of the United States Agency for International Development (USAID), to provide assistance for a pilot program to improve the nutritional status of at-risk five-year old children in salmas district, Afghanistan.

Directs the Secretary to establish a program to provide supplemental nutrition assistance for such children.

Authorizes the Secretary to provide technical assistance to support the planning, development, and implementation of programs to improve the nutritional status of at-risk five-year old children in salmas district, Afghanistan.

Directs the Secretary to provide technical assistance to support the planning, development, and implementation of programs to improve the nutritional status of at-risk five-year old children in salmas district, Afghanistan.

Amends the Food Security and Nutrition Act of 2008 to authorize the Secretary to provide assistance for a pilot program to improve the nutritional status of at-risk five-year old children in salmas district, Afghanistan.

Directs the Secretary to establish a program to provide supplemental nutrition assistance for such children.
-----:16
TABLE OF CONTENTS: 
 Title I: Tay-Sachs 
 Title II: Genetic Epidemiology 
 Title III: Radiological and Medical Research 
Title I: Tay-Sachs
 - Directs the Secretary of Health and Human Services to conduct a study to determine the prevalence and distribution of Tay-Sachs. 
Title II: Genetic Epidemiology
 - Directs the Secretary to conduct a study to determine the prevalence and distribution of Tay-Sachs in children. Authorizes the Secretary to make grants to public or nonprofit private entities for the purpose of conducting this study. 
Directs the Secretary to: (1) determine the prevalence of Tay-Sachs in the United States; and (2) conduct and report on research to determine the prevalence and distribution of such disorder in children. Authorizes the Secretary to make grants to public or nonprofit private entities for the purpose of conducting this study. 
Title III: Radiological and Medical Research
 - Directs the Secretary to conduct and report on research to determine the prevalence and distribution of Tay-Sachs in children. Authorizes the Secretary to make grants to public or nonprofit private entities for the purpose of conducting this study.
-----:17
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an arrangement with the National Cancer Institute to study and report to Congress on the treatment of individuals with primary cutaneous malignant melanoma.
-----:18
TABLE OF CONTENTS: 
 Title I: General Provisions 
 Title II: Provisions 
 Title III: Special Provisions 
 Title IV: Effective Dates 
Title I: General Provisions
 - Provides that the provisions of this title shall apply to all authorities under the laws of the United States, including but not limited to the Secretary of Health and Human Services, the Director of the Centers for Disease Control and Prevention, and the Director of the National Institutes of Health. 
Title II: Provisions
 - Provides that the provisions of this title shall apply to all authorities under the laws of the United States, including but not limited to the Secretary of Health and Human Services, the Director of the Centers for Disease Control and Prevention, and the Director of the National Institutes of Health. 
Title III: Special Provisions
 - Provides that the provisions of this title shall apply to all authorities under the laws of the United States, including but not limited to the Secretary of Health and Human Services, the Director of the Centers for Disease Control and Prevention, and the Director of the National Institutes of Health.
-----:19
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to convene a panel of experts to review and make recommendations on the current state of the science relating to the diagnosis of pji (total joint infection) and how it may be improved. Requires the Secretary to: (1) review this panel's recommendations at least once every five years; and (2) report to the appropriate congressional committees on the review's findings and recommendations.
-----:20
Expresses the sense of the Congress that: (1) the Food and Drug Administration should issue specific guidance on the use of certain chemotherapy agents to reduce the risk of adverse events in patients receiving such chemotherapy; and (2) the Department of Health and Human Services should conduct a study to determine the percentage of patients who receive such chemotherapy agents for whom there has been a documented case of adverse events, and to determine the percentage of such patients who receive such chemotherapy agents for which there has been a documented case of adverse events, giving priority to patients who received such chemotherapy agents prior to or at the time of surgery for cancer, and who received such chemotherapy agents at the time of surgery for cancer.
Directs the Secretary of Health and Human Services to conduct a study to determine the percentage of patients who receive such chemotherapy agents for which there has been a documented case of adverse events, and to determine the percentage of such patients who receive such chemotherapy agents for which there has been a documented case of adverse events, giving priority to patients who received such chemotherapy agents prior to or at the time of surgery for cancer.
-----:21
Directs the Secretary of Health and Human Services to establish a grant program to support research, development, demonstration, and application of new materials and technologies for the prevention and control of dental caries. Authorizes appropriations.
-----:22
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to offer to enter into an agreement with the National Academy of Sciences to review the current state of knowledge about the role of certain transcription factors in human autoimmune diseases. Authorizes the Secretary to make grants to the Institute of Medicine of the National Academy of Sciences to support research into the role of these transcription factors in the pathogenesis of such diseases.
-----:23
Microbicide Research Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to submit to the appropriate congressional committees a report containing recommendations on the use of certain macrolideerythromycins for the prevention of infectious diseases.

Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA), to report to the appropriate congressional committees on the use of certain macrolideerythromycins for the prevention of infectious diseases.
-----:24
This report describes a case of pseudozymais fung infiltration, which was reported as an invasive result of chemotherapy after reinduction of the blood drug cytarabine.
-----:25
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide assistance to the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to conduct and support research into: (1) the relationship between diabetic foot ulcerations and complications of kidney disease; (2) the relationship between diabetic foot ulcerations and renal disease; and (3) whether there is a causal relationship between diabetic foot ulcerations and renal disease.
 Directs the Secretary to: (1) conduct and support research into whether there is a causal relationship between diabetic foot ulcerations and complications of kidney disease; and (2) conduct a study to determine whether there is a causal relationship between diabetic foot ulcerations and renal disease.
-----:26
Authorizes the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to enter into cooperative agreements with the National Heart, Lung, and Blood Institute to: (1) conduct basic, clinical, and translational research to evaluate the role of the sigma1180v gene in the development of heart disease; and (2) provide technical assistance to the Institute to support such research.
Directs the Secretary, acting through the Director of the CDC, to: (1) conduct a basic, clinical, and translational research to evaluate the role of the sigma1180v gene in the development of heart disease; and (2) provide technical assistance to the Institute to support such research.
-----:27
Patients with chronic retinal detachments who should have their retinal detachments best done during working hours and who may be difficult to predict due to poor views, may be difficult to evaluate, and may be difficult to treat.
-----:28
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate activities of the Centers with respect to the research, prevention, and treatment of human disease. Authorizes the Secretary to make grants to the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Child Health and Human Development, and the National Institute of Diabetes and Digestive and Kidney Diseases, to support such activities.
-----:29
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide technical assistance to the Director of the National Heart, Lung, and Blood Institute, through the National Institute of Diabetes and Digestive and Kidney Diseases, in order to expand, intensify, and coordinate research programs related to obesity and heart disease.

Requires the Director of the CDC, in order to expand, intensify, and coordinate research programs related to obesity, to provide technical assistance to the Director of the National Heart, Lung, and Blood Institute, through the National Institute of Diabetes and Digestive and Kidney Diseases.
-----:30
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and analyze data on the impact of additive manufacturing methods on the production of dental prostheses, and (2) establish a system to collect and analyze such data.
Directs the Secretary, acting through the Director of the CDC, to: (1) collect and analyze data on the impact of additive manufacturing methods on the production of dental prostheses; and (2) establish a system to collect and analyze such data.
-----:31
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to conduct a study to determine the incidence and prevalence of certain conditions affecting human hair.Amends the Public Health Service Act to authorize the Secretary to make grants to public and nonprofit private entities for the purpose of conducting studies to determine the incidence and prevalence of certain conditions involving human hair.Requires the Director of the National Institutes of Health, acting through the Director of the National Institute of Diabetes and Digestive and Kidney Diseases, to conduct a study to determine the incidence and prevalence of certain conditions involving human hair.
-----:32
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and analyze data on the course and incidence of cardiac toxicity in patients with relapsing multiple sclerosis who received mitoxantrone therapy during the period beginning on January 1, 2004, and ending on June 1, 2008; and (2) report on such data to the appropriate congressional committees.
-----:33
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to provide technical assistance to the Director of the National Institute of Diabetes and Digestive and Kidney Diseases in the development and implementation of a plan to improve the quality of health care in the United States. Authorizes the Secretary to make grants to the Institute, on a competitive basis, to support research to: (1) improve the health care quality of individuals with chronic diseases; (2) conduct research to determine the pathogenesis, diagnosis, and treatment of such diseases; and (3) report on such research to the Director of the Centers for Disease Control and Prevention. Expresses the sense of the Department of Health and Human Services that: (1) the National Institutes of Health should continue to support research to improve the health care quality of individuals with chronic diseases, including research to determine the pathogenesis, diagnosis, and treatment of such diseases; and (2) the Center should continue to support research to improve the health care quality of individuals with such diseases, including research to determine the etiology of such diseases and to report on such research to the Director of the Centers for Disease Control and Prevention.
-----:34
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) conduct and support research to expand the understanding of the role of vitamin d in the prevention and control of chronic liver disease, and (2) provide for the conduct and support of additional research to expand the understanding of the role of vitamin d in the prevention and control of other chronic liver diseases.
Directs the Secretary, acting through the Director of the CDC, to: (1) conduct and support research to expand the understanding of the role of vitamin d in the prevention and control of chronic liver disease, and (2) provide for the conduct and support of additional research to expand the understanding of the role of vitamin d in the prevention and control of other chronic liver diseases.
-----:35
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the Institute of Medicine to conduct a study on the safety and effectiveness of the use of a laser therapy to treat prostate cancer.
Requires the Secretary, acting through the Director of the National Institutes of Health (NIH), to: (1) conduct a study to evaluate the safety and effectiveness of the use of a laser therapy for the treatment of prostate cancer; and (2) report to Congress on such study's results.
-----:36
(This measure has not been amended since it was reported to the Institute of Medicine on June 22, 2012. The summary of that version is repeated here.)

 extramedry pulmonary hematopoiesis being described as a rareetiological factor which causes multifactorial complications with extramedry pulmonary hematopoiesis in the lungs.

Authorizes the Secretary of Health and Human Services to make grants to public and nonprofit private entities for the purpose of carrying out research with respect to such extramedry pulmonary hematopoies is being described as a rareetiological factor which causes multifactorial complications with extramedry pulmonary hematopoiesis in the lungs.
-----:37
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to enter into an agreement with the National Academy of Sciences (NAS) to review the current state of knowledge about certain proteins that are important in the genome of human and other animals. Authorizes the Secretary to: (1) enter into such agreements to study those proteins in more detail, and (2) use the results of those studies to develop new approaches to target those proteins.
-----:38
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Cancer Institute to study and report to the Secretary and the public on the costs and benefits associated with screening and treatment of individuals with melanoma. Authorizes the Secretary to make grants to nonprofit private entities for the purpose of assisting such entities in carrying out such study. Requires the Secretary to report to the appropriate congressional committees on the costs and benefits associated with screening and treatment of individuals with melanoma.
-----:39
Directs the Secretary, acting through the Director of the National Institutes of Health (NIH), to expand, intensify, and coordinate the research programs of the NIH related to the use of neurotrophic factors to prevent and treat diseases of the central nervous system, such as diabetes.

Authorizes the Secretary to: (1) make grants to, or enter into contracts or cooperative agreements with, public or nonprofit private entities for the purpose of conducting research with respect to the use of neurotrophic factors to prevent or treat diseases of the central nervous system; and (2) expand, intensify, and coordinate research programs of the NIH related to neurotrophic factors to prevent and treat diseases of the central nervous system, such as diabetes.
-----:40
Authorizes the Secretary of Health and Human Services to enter into a cooperative agreement with the National Institutes of Health to conduct research related to the diagnosis and treatment of biliary hamartomas.
Directs the Secretary, acting through the Director of the National Institutes of Health, to: (1) conduct research related to biliary hamartomas; and (2) report to the Congress on such research.
-----:41
Human Rights Protection Act of 2016 This bill authorizes the President to provide assistance, including through multilateral, nongovernmental, and faith-based organizations, to promote and protect the human rights of people whose rights are not on the basis of their gender identity or gender identity because of their sexual orientation or gender identity. It expresses the sense of the Congress that the President, acting through the United States Agency for International Development (USAID), should: review USAID's support for activities to protect the human rights of people whose rights are not on the basis of their gender identity or gender identity to determine whether it can be used to assist in achieving universal access to health care and prevention of hiv and hepatitis virus infections in Nigeria; and support activities to protect the human rights of people whose rights are not on the basis of their gender identity or gender identity because of their sexual orientation or gender identity. It expresses the sense of the Congress that the United States should support efforts to protect the human rights of people whose rights are not on the basis of their gender identity or gender identity because of their sexual orientation or gender identity.
-----:42
Long-Term Care Insurance Program in Korea - Amends title XVIII (Medicare) of the Social Security Act, as amended by the Health Insurance Portability and Accountability Act of 1996 (HIPAA), to require the Secretary of Health and Human Services (HHS) to provide for the establishment of a long-term care (LTC) insurance program in korea.

Defines LTC insurance as life insurance for LTC facilities that provide care and services to individuals over the age of 65.

Requires the Secretary to establish: (1) a list of drugs and biologics that may be considered potentially inappropriate for use in elderly patients, (2) a formula for determining the appropriate LTC grade for each LTC facility, and (3) quality of care standards for each facility.

Directs the Secretary, acting through the Director of the Agency for Healthcare Research and Quality (AHRQ), to carry out a pilot program to test whether LTC insurance can reduce the incidence of inappropriate medication use in nursing facilities.
-----:43
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to provide assistance to develop and implement a comprehensive strategy to reduce the incidence and mortality rates of extrahec portal hypertension (evosplenism) around the world by carrying out activities to improve the diagnosis, prevention, and treatment of evosplenism, with an emphasis on countries with high rates of evosplenism, particularly in children. Requires the Secretary to coordinate activities of the United States Agency for International Development and other agencies of the Department of Health and Human Services to support the development and implementation of such a strategy. Requires the Secretary to report to the Congress on the status of evosplenism in the United States, with an emphasis on countries with high rates of evosplenism, including how best to implement a comprehensive strategy to reduce the incidence and mortality rates of evosplenism around the world by carrying out activities to improve the diagnosis, prevention, and treatment of evosplenism, with an emphasis on countries with high rates of evosplenism, including how best to implement a comprehensive strategy to reduce the incidence and mortality rates of evosplenism in children.
-----:44
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into agreements with the National Heart, Lung, and Blood Institute and the Institute of Diabetes and Digestive and Kidney Diseases of the Health Resources and Services Administration of the Department of Health and Human Services, for the purpose of carrying out research, development, and demonstration projects to improve the health care services provided to individuals with heart disease. Authorizes the Secretary to make grants to such Institutes for projects to improve the health care services provided to individuals with heart disease.
-----:45
Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to convene a panel of experts to review and make recommendations on the current state of knowledge about mes (a cluster of inflammatory conditions associated with diabetes that may play a causal role in insufficient physical activity, insufficient physical activity accompanied with increased or inappropriate fat accumulation, and may increase the risk of cardiovascular disease) in Americans.

Directs the Secretary to: (1) convene a panel of experts to review and make recommendations on the current state of knowledge about mes (a cluster of inflammatory conditions associated with diabetes that may play a causal role in insufficient physical activity, insufficient physical activity accompanied with increased or inappropriate fat accumulation, and may increase the risk of cardiovascular disease) in Americans; and (2) report to the appropriate congressional committees on these recommendations and on progress made in implementing the recommendations.

Requires the Director of the Agency for Healthcare Research and Quality to convene a panel of experts to review and make recommendations on the current state of knowledge about mes (a cluster of inflammatory conditions associated with diabetes that may play a causal role in insufficient physical activity, insufficient physical activity accompanied with increased or inappropriate fat accumulation, and may increase the risk of cardiovascular disease) in Americans.
-----:46
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to provide for the conduct of a study to determine the role of educational intervention (patient-based teaching) to improve the prescribing skill of second-year medical students.
-----:47
Expresses the sense of the Senate that the Secretary of Health and Human Services should fully consider the following factors in determining the cause of the pulmonary tuberculosis outbreak in Washington, D.C., in 2003 and 2004: (1) the extent to which illicit drug use may be a factor; (2) the extent to which individuals in Washington, D.C., who contracted pulmonary tuberculosis during 2003 and 2004 were involved in illicit drug use; (3) the extent to which individuals in Washington, D.C., who contracted pulmonary tuberculosis during 2003 and 2004 were involved in illicit drug use; and (4) measures to reduce the incidence of pulmonary tuberculosis in Washington, D.C., in the future.

Authorizes the Secretary to enter into agreements with the National Heart, Lung, and Blood Institute and the Institute of Medicine to conduct epidemiologic research regarding pulmonary tuberculosis in Washington, D.C., in the future.
-----:48
Instructs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and review data on hospital-acquired vancomycin resistance to determine the extent to which such resistance is associated with hospital-acquired vancomycin failure; (2) undertake further studies to determine the incidence and prevalence of hospital-acquired vancomycin resistance and the factors associated with hospital-acquired vancomycin failure; and (3) report on hospital-acquired vancomycin resistance data and efforts to reduce such resistance.

Directs the Secretary, acting through the Administrator of the Centers for Disease Control and Prevention (CDC), to: (1) collect and review data on hospital-acquired vancomycin resistance to determine the extent to which such resistance is associated with hospital-acquired vancomycin failure; (2) undertake further studies to determine the incidence and prevalence of hospital-acquired vancomycin resistance and the factors associated with hospital-acquired vancomycin failure; and (3) report on such resistance data and efforts.
-----:49
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and analyze data on the use of villiptin (Voluntary Prescription Drug Benefit Program) by individuals with diabetes, and (2) report such data to the National Institutes of Health (NIH).
-----:50
2010oc 2010 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to increase the number of specimens analyzed for enterovirus infections in the National Institute of Allergy and Infectious Diseases.

Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) increase the number of specimens analyzed for enterovirus in the National Institute of Allergy and Infectious Diseases; and (2) give priority to increasing the number of specimens analyzed for enterovirus in disadvantaged populations.

Directs the Secretary, acting through the Director of the CDC, to: (1) increase the number of specimens analyzed for enterovirus in the National Institute of Allergy and Infectious Diseases; and (2) give priority to increasing the number of specimens analyzed for enterovirus in disadvantaged populations.
-----:51
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make grants to eligible public or nonprofit private entities to carry out a program to educate the public and health care providers about dysphagia, and the treatment of such condition. Authorizes appropriations.
-----:52
Directs the Secretary of Health and Human Services to ensure that the National Institute of Diabetes and Digestive and Kidney Diseases shall continue to support the research, development, and clinical activities of the U.S. Food and Drug Administration through grants, contracts, and cooperative agreements with other research institutions as well as with the Department of Health and Human Services (HHS) under the Food, Drug, and Cosmetic Act. Requires the Secretary to ensure that such research shall: (1) continue to support the research efforts of the Institute through grants, contracts, and cooperative agreements with other research institutions as well as with the HHS under the Food, Drug, and Cosmetic Act; and (2) be supported by amounts appropriated to HHS from funds appropriated to HHS under the Federal Food, Drug, and Cosmetic Act.
-----:53
Drug Delivery System - Provides for the development of a drug delivery system that includes: (1) an electrical barrier that maintains a constant thickness across the delivery of molecules and enhances delivery of such molecules; (2) an active ingredient that maintains a constant thickness across the delivery of molecules and enhances delivery of such molecules; and (3) a delivery system that contains an active ingredient that maintains a constant thickness across the delivery of molecules and enhances delivery of such molecules.
-----:54
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide for a study on the impact of physical exercise on rheumatoid arthritis patients.
-----:55
TABLE OF CONTENTS: 
 Title I: Scientific Review 
 Title II: Public Health Impact 
 Title III: Food Amendments 
Food Amendments of 1993 - 
Title I: Science Review
 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to conduct a scientific review of the current state of science regarding the impact of food on human health. Requires the Secretary to: (1) review the current state of science regarding the impact of food on human health; (2) evaluate the current state of science regarding the impact of food on human health; and (3) report to the Congress. Directs the Secretary to include in the report a summary of the current state of science regarding the impact of food on human health. 
Title II: Public Health Impact
 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to provide for a scientific review of the current state of science regarding the impact of food on human health. Directs the Secretary to: (1) review the current state of science regarding the impact of food on human health; (2) evaluate the current state of science regarding the impact of food on human health; and (3) report to the Congress.
-----:56
Directs the Secretary of Health and Human Services, acting through the Agency for Healthcare Research and Quality, to expand, intensify, and coordinate activities of the Centers for Disease Control and Prevention (CDC) related to the research, prevention, and treatment of heart, blood vessel, lung, and muscle diseases. Requires the Director of the CDC, acting through the Director of the National Institutes of Health (NIH), to: (1) conduct research to expand the understanding of how heart, blood vessel, lung, and muscle diseases arise; (2) direct the National Institutes of Health to expand, intensify, and coordinate activities of the CDC related to heart, blood vessel, lung, and muscle diseases; and (3) conduct research to expand the understanding of how heart, blood vessel, lung, and muscle diseases arise. Permits the Director of the CDC, acting through the Director of the National Institutes of Health (NIH), to: (1) conduct research to expand the understanding of how heart, blood vessel, lung, and muscle diseases arise; and (2) direct the National Institutes of Health to expand, intensify, and coordinate activities of the CDC related to heart, blood vessel, lung, and muscle diseases.
-----:57
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Heart, Lung, and Blood Institute to conduct a study on the accuracy of the method of collecting and reporting meningioma tissue samples.

Requires the Secretary, acting through the Administrator, to: (1) conduct a study on the accuracy of the method of collecting and reporting meningioma tissue samples; and (2) report on the results of such study to the public.
-----:58
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect, analyze, and make available to the public data on the incidence and prevalence of pneumoconiosis, including data on treatment options, provided that such data are taken from patients who were treated with pneumoconiosis prior to July 1, 2005; and (2) ensure that such data are made available to the public on a publicly accessible website.
-----:59
Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to report to the appropriate congressional committees on the stability of analytes in serum used in clinical laboratories.
-----:60
United States Food and Nutrition Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to add certain information relating to the consumption of milk by individuals under the age of 18 years old that may be reported to the Food and Drug Administration by the Secretary of Health and Human Services.
-----:61
Use of the smart database to collect data on the number of each conserved domain in each five- genome.
-----:62
Tuberculosis Research Act of 2010 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the CDC related to the collection and analysis of data on tuberculosis.

Requires the Director of the CDC, in carrying out activities to increase awareness of tuberculosis, to: (1) increase the number of surveillance sites; (2) expand the scope of activities for which data are available; and (3) coordinate activities with the Director of the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH).

Requires the Director of the Centers for Disease Control and Prevention (CDC), acting through the Director of the National Heart, Lung, and Blood Institute, to expand, intensify, and coordinate activities of the CDC related to tuberculosis.

Authorizes the Director of the CDC, in carrying out activities to increase awareness of tuberculosis, to: (1) increase the number of surveillance sites; (2) expand the scope of activities for which data are available; and (3) coordinate activities with the Director of the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH).
-----:63
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Cancer Institute to conduct a study to evaluate the efficacy and safety of once-daily administration of pde5-is, administered by an experienced prostate cancer surgeon, for the treatment of prostate cancer. Requires the Secretary to: (1) report the results of the study on the Internet and make the information available to the public; and (2) conduct or support research to expand the understanding of penile rehabilitation following prostate cancer.
-----:64
Amends the National Institute of Standards and Technology Organization Act to require the Secretary of Commerce, acting through the Director of the National Institute of Standards and Technology, to submit to the Congress a report on multi-color qd lasers using implantation induced intermixing.
-----:65
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to convene a panel of experts to review the current state of knowledge concerning the use of lincomycin and pirlindycin as antimicrobial drugs.
-----:66
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to report to the Congress on the status of the evidence relating to the effectiveness of the combination of chemotherapy and fluorouracil in patients with advanced penile cancer.
-----:67
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities related to the prevention and control of human hook infection.
-----:68
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) undertake a comprehensive study to determine the prevalence and clinical characteristics of ovov and whether it is the cause of severe pediatric gastroenteritis in countries with a high incidence of such infections; and (2) report the results of such study to the Congress.
-----:69
Multicystic dysplastic kidney syndrome is a dominant condition that causes abnormalities of the kidney and is associated with other multisystemic disorders of the renal system. Authorizes the Secretary of Health and Human Services to expand, intensify, and coordinate activities of the National Institutes of Health relating to multicystic dysplastic kidney syndrome, including to conduct or support research to: (1) improve the definition of the condition, (2) identify the mutations that cause it, (3) determine the prevalence of the condition, and (4) identify treatment options for individuals with the condition. Directs the Secretary to: (1) conduct or support research to improve the definition of dysplastic kidney syndrome, (2) identify the mutations that cause it, (3) determine the prevalence of the condition, and (4) identify treatment options for individuals with the condition. Requires the Director of the National Institutes of Health (NIH) to expand, intensify, and coordinate activities of the NIH relating to multicystic dysplastic kidney syndrome to: (1) improve the definition of the condition, (2) identify the mutations that cause it, (3) determine the prevalence of the condition, and (4) identify treatment options for individuals with the condition.
-----:70
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to convene a panel of experts to review the current state of the science relating to the use of blood clotting factors as a risk assessment for cardiovascular disease.
-----:71
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to report to the appropriate congressional committees on the status of the use of intrinsicangiogenic biomarkers in clinical trials for antiangiogenic therapy.
-----:72
(This measure has not been amended since it was reported to the House on May 14, 2014. This measure has not been amended since it was reported to the House on May 14, 2014.
-----:73
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make available to the public: (1) information on the safety and effectiveness of intravitreal injections for the treatment of age-related retinal disease, including data on safety and effectiveness of the intravitreal injection protocol; and (2) assistance in disseminating such information to health care providers. Authorizes the Secretary to make grants to public and nonprofit private entities for the conduct or support of research to evaluate the safety and effectiveness of intravitreal injections for the treatment of age-related retinal disease, including data on safety and effectiveness of the intravitreal injection protocol.
-----:74
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to enter into an agreement with the National Academy of Sciences to conduct a study on the effect of glass ionomers used in home dental bleaching systems on the release of fluoride and hydrogen acid during the bleaching process. Requires the Secretary to: (1) report to the Congress on such study's results; and (2) conduct another study, this time on the effect of glass ionomers used in home dental bleaching systems on the release of fluoride and hydrogen acid during the bleaching process.
-----:75
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the Institute of Medicine to conduct a study to review the current state of knowledge about the effectiveness and safety of the flexible brooscopy procedure. Requires the Secretary to report to the appropriate congressional committees on the study and to make any recommendations for improvements in the performance and safety of the flexible brooscopy procedure.
-----:76
metabolic syndrome and cardiovascular risk factors - Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to convene a panel of experts to review the scientific evidence relating to metabolic syndrome and cardiovascular risk factors in individuals who are at high risk for diabetes.

Directs the Secretary to: (1) convene a panel of experts to review the scientific evidence relating to metabolic syndrome and cardiovascular risk factors in individuals who are at high risk for diabetes; (2) determine which of these risk factors are the most strongly associated with metabolic syndrome and which of these risk factors are the most closely predictive of diabetes, cardiovascular disease, or other conditions.
-----:77
Directs the Secretary, acting through the Director of the Centers for Disease Control and Prevention, to report to the appropriate congressional committees on the status of the research efforts of the Department of Health and Human Services regarding rheumatoid arthritis.
-----:78
Expresses the sense of the Congress that the Department of Health and Human Services should provide for the conduct and support of research to determine the incidence and prevalence of prostate cancer in American men, and the reasons for the incidence and prevalence of such cancer in such men. Requires the Director of the Agency for Healthcare Research and Quality to conduct and support research to determine the incidence and prevalence of prostate cancer in American men, and the reasons for the incidence and prevalence of such cancer in such men. Directs the Secretary of Health and Human Services to: (1) conduct and support research to determine the incidence and prevalence of prostate cancer in American men, and the reasons for the incidence and prevalence of such cancer in such men; and (2) provide for the conduct and support of research to determine the incidence and prevalence of prostate cancer in American men and the reasons for the incidence and prevalence of such cancer in such men.
-----:79
This bill directs the National Institutes of Health (NIH) to expand, intensify, and coordinate research efforts to: (1) identify new risk or protective factors associated with micrornablastoma, (2) evaluate the role of specified molecules in the signaling system of micrornablastoma, and (3) identify new targets for therapeutic treatments of micrornablastoma.
-----:80
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to convene a panel of experts to review and make recommendations on: (1) ablative laser treatment that may be used to reduce and treat age-related problems on the skin of adult women; and (2) other methods to reduce and treat age-related problems on the skin of adult women.

Requires the Director of the CDC to: (1) convene a panel of experts to review and make recommendations on ablative laser treatment that may be used to reduce and treat age-related problems on the skin of adult women; and (2) establish a grant program to support research to determine whether ablative laser treatment may be used to reduce and treat age-related problems on the skin of adult women.

Amends the Public Health Service Act to require the Secretary to: (1) provide support for research to determine whether ablative laser treatment may be used to reduce and treat age-related problems on the skin of adult women; and (2) conduct or support research to determine whether ablative laser treatment may be used to reduce and treat age-related problems on the skin of adult women.
-----:81
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to convene a panel of experts to review the current state of the analytical method for determining concentration with high sensitivity of cardiac biomarkers in patients with acute coronary syndrome, and to submit recommendations to the Secretary for improvements in such method.
-----:82
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to provide for the conduct and support of research by the Department of Health and Human Services on the diagnosis, prevention, and treatment of pancreatic cancer.
-----:83
Laboratory Safety Act of 1993 - Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide for the establishment of a national database on laboratory errors that occur during the testing phase of point-of-care (poct) tests.
-----:84
Amends the Higher Education Act of 1965 to authorize the Secretary of Education to make grants to institutions of higher education for research to determine the incidence and prevalence of pain, fatigue, and obesity among students who participate in athletics and physical activities at such institutions.
Directs the Secretary to: (1) make grants to such institutions to conduct or support research to determine the incidence and prevalence of pain, fatigue, and obesity among students who participate in athletics and physical activities at such institutions; and (2) conduct a study to determine the incidence and prevalence of pain, fatigue, and obesity among students who participate in athletics and physical activities at such institutions.
-----:85
Common Sense Medical Malpractice Reform Act of 2009 - States that it is the policy of the United States that, upon the recommendation of the Director of the Agency for Healthcare Research and Quality, it shall be unlawful for any physician or other employee of the United States to withhold from any patient admitted to a hospital, or to require such a physician or employee to withhold from any patient admitted to a hospital, if the physician or employee has reason to believe that the patient is perishable or that the patient may die.

Authorizes the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants to public and nonprofit private entities to carry out research to improve the quality of care provided to patients following cardiac arrest in hospital settings.

Amends the Public Health Service Act to require the Secretary to expand, intensify, and coordinate research activities to improve the quality of care provided to patients following cardiac arrest in hospital settings.
-----:86
Nuclear Regulatory Commission Act of 1978 - Directs the Secretary of Energy, acting through the Director of the Agency for Toxic Substances and Disease Registry, to submit to the Congress a report containing: (1) an analysis of specified factors that affect the performance of radionuclide storage facility design; (2) a description of specific measures that have been taken to address failures in the performance of the design; and (3) recommendations for corrective actions to reduce the risk of future failures. 
Requires the Secretary to report to the appropriate congressional committees on: (1) an analysis of specified factors that affect the performance of the design for storage of high-level nuclear wastes in the deep subsurface; (2) a description of specified measures that have been taken to address failures in the performance of the design; and (3) recommendations for corrective actions to reduce the risk of future failures. 
Directs the Secretary to submit to the appropriate congressional committees: (1) an analysis of specified factors that affect the performance of the design for storage of high-level nuclear wastes in the deep subsurface; (2) a description of specified measures that have been taken to address failures in the performance of the design; and (3) recommendations for corrective actions to reduce the risk of future failures.
-----:87
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants to, or enter into contracts with, public or nonprofit private entities to carry out this study. Authorizes appropriations.
-----:88
Expresses the sense of the Congress that: (1) the Food and Drug Administration should comprehensively review the scientific evidence relating to the safety and effectiveness of vitamin E supplementation in women's bodies; and (2) the Department of Health and Human Services should promulgate regulations to ensure that women are provided with accurate information about the safety and effectiveness of vitamin E supplementation in women's bodies.
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to: (1) conduct and support research to expand the understanding of the causes of oxygen free radical damage and the relationship between oxygen free radical damage and cardiovascular disease; and (2) provide for the conduct and support of additional research to expand the understanding of the causes of oxygen free radical damage and the relationship between oxygen free radical damage and cardiovascular disease.
Requires the Director of the National Institutes of Health, acting through the Director of the Centers for Disease Control and Prevention, to: (1) conduct and support research to expand the understanding of the causes of oxygen free radical damage and the relationship between oxygen free radical damage and cardiovascular disease; and (2) provide for the conduct and support of additional research to expand the understanding of the causes of oxygen free radical damage and cardiovascular disease.
-----:89
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Academy of Sciences to review the scientific evidence relating to the use of ophthalmologic agents in the treatment of amblyopia, and to submit a report to the Congress. Authorizes appropriations.
-----:90
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide assistance to the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate research programs related to asthma and migraine.
-----:91
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate research programs to: (1) improve the safety of bracket bonding techniques; and (2) evaluate the effectiveness of new bracket bonding technologies.
-----:92
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate activities of the Centers for Disease Control and Prevention in order to: (1) monitor and analyze the impact of changes in bone density, including savesay savesay, on the health of individuals with hereditary bone diseases; (2) monitor the impact of changes in bone density, including savesay, on the health of individuals with hereditary bone diseases; and (3) assess the current state of research in such diseases. Authorizes the Secretary to: (1) provide grants to, or enter into contracts with, public or nonprofit private entities for the purpose of carrying out such activities; and (2) deploy personnel and resources to the Centers for Disease Control and Prevention in order to monitor and analyze the impact of changes in bone density, including savesay, on the health of individuals with hereditary bone diseases.
-----:93
Requires the Secretary, acting through the Director of the National Institutes of Health, to report to the appropriate congressional committees regarding the extent to which the variations reported in this report are consistent with the results of other studies regarding cnvs in the human genome.
-----:94
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the Institute of Medicine to conduct a study on the role of certain transcription factors in the pathogenesis of secondary brain injury following traumatic brain injury.
-----:95
Big Data in Critical Care discusses the use of data in critical care with a focus on the big data that is sweep of digital medical information that has accumulated in the clinical setting and the use of scoring systems to assess the severity of acute care.
-----:96
Prohibits the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), from establishing or enforcing standards for the collection of antibiogram data from hospitals for which specified antimicrobial agents are used.
Directs the Secretary to: (1) collect and analyze antibiogram data from all hospitals for which specified antimicrobial agents were used during the most recent period for which data were available; and (2) establish a system to collect and analyze antibiogram data from all hospitals at the same time and on the same basis as the national data.
-----:97
Prescribes the methods and implementation of the aggregate hospitalization and death reporting activity ( ahdra) proposed by the council of state and territorial epidemiologists as part of an overall national surveillance strategy for the 2009 pandemic influenza.

Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) establish and maintain a database of data from all states and U.S. territories that were requested to report laboratory-confirmed influenza hospitalizations and deaths during the 2009 pandemic influenza pandemic; (2) provide the data to the National Institute of Allergy and Infectious Diseases (NIAID) under the National Institutes of Health (NIH); (3) develop and maintain a database of data from all laboratory-confirmed influenza cases during the 2009 pandemic influenza pandemic; and (4) establish and maintain a database of data from all laboratory-confirmed and syndromic influenza cases during the 2009 pandemic influenza pandemic.

Requires the Director of NIH, acting through the Director of NIAID, to develop and maintain a database of data from all laboratory-confirmed and syndromic influenza cases during the 2009 pandemic influenza pandemic.
-----:98
bilateral shoulder dislocations are the most type of injury without any traumatic seizure disorder and tend to be associated with post-traumatic seizure disorder and tend to be associated with bilateral shoulder dislocations without any systemic trauma, but there are other cases of such injury where the injury takes place on either side of the shoulder and there is no predisposition of pain or restriction of movement.

 bilateral shoulder dislocations are the most type of injury without traumatic seizure disorder and tend to be associated with post-traumatic seizure disorder and tend to be associated with bilateral shoulder dislocations without systemic trauma, but there are other cases of such injury where the injury takes place on either side of the shoulder and there is no predisposition of pain or restriction of movement.

Bilateral shoulder dislocations are the most type of injury without traumatic seizure disorder and tend to be associated with post-traumatic seizure disorder and tend to be associated with bilateral shoulder dislocations without systemic trauma, but there are other cases of such injury where the injury takes place on either side of the shoulder and there is no predisposition of pain or restriction of movement.
-----:99
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to enter into a contract with the National Academy of Medicine (formerly known as the Institute of Medicine) to study and report on the status of data on the health status of members of the National Birth Cohort.
Requires the Director of the CDC to: (1) enter into a cooperative agreement with the National Institute of Diabetes and Digestive and Kidney Diseases to conduct a study to review the status of data on the health status of members of the National Birth Cohort, and (2) report to the Congress on such study.
